## Abstract The HER2 (cβerbBβ2) receptor is overexpressed in a variety of human malignant tumors and, in breast carcinoma, has been identified as a target for antiβHER2βdirected therapy with the monoclonal antibody (MAb) trastuzumab. The aim of this retrospective study was to evaluate immunohistoch
Prognostic significance of peritumoural inflammation in invasive urothelial bladder carcinoma
β Scribed by Mihatsch, M.J. ;Rist, M. ;Romppanen, T. ;Rutishauser, G.
- Publisher
- Springer
- Year
- 1979
- Tongue
- English
- Weight
- 810 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
β¦ Synopsis
Peritumoural inflammation consisting of lymphocytes, plasma cells and lymph follicles is present in two thirds of invasive urothelial bladder carcinomas. This type of inflammation is significantly rarer in advanced tumour stages (P3, P/) and its presence is a favourable prognostic factor. The mean survival time in patients with this type of inflammation is 26.1 months compared to only 14.8 months in patients without. All other forms of inflammation e. g. eosinophilic or polymorphonuclear leukocytes have no relation with prognosis. The significant prognostic value of lympho-plasmocytic inflammation may be considered as local expression of immunological host resistance.
π SIMILAR VOLUMES
## Background: 5-fluorouracil (5-fu) is an anticancer agent clinically used against various cancers including bladder carcinoma. 5-fu inhibits thymidylate synthase (ts) and blocks dna synthesis. ts is the key enzyme in the catalysis of the methylation from deoxyuridine monophosphate (dump) to deoxy
## Abstract ## BACKGROUND Thymidine kinase (TK) plays a key role in the complimentary or alternative salvage pathway of pyrimidine synthesis. Little is known about the significance of TK activity in bladder carcinoma. The authors examined the activity of TK in 55 patients with bladder carcinoma to
## Abstract ## BACKGROUND 5βFluorouracil (5βFU), an antitumor agent, is used clinically against a variety of malignancies, including bladder carcinoma. 5βFU is a prodrug, and orotate phosphoribosyltransferase (OPRT) is the principal enzyme that converts 5βFU directly into an active antitumor metab